Large-scale proteogenomics characterization of microproteins in Mycobacterium tuberculosis.

Publication date: Dec 28, 2024

Tuberculosis remains a burden to this day, due to the rise of multi and extensively drug-resistant bacterial strains. The genome of Mycobacterium tuberculosis (Mtb) strain H37Rv underwent an annotation process that excluded small Open Reading Frames (smORFs), which encode a class of peptides and small proteins collectively known as microproteins. As a result, there is an overlooked part of its proteome that is a rich source of potentially essential, druggable molecular targets. Here, we employed our recently developed proteogenomics pipeline to identify novel microproteins encoded by non-canonical smORFs in the genome of Mtb using hundreds of mass spectrometry experiments in a large-scale approach. We found protein evidence for hundreds of unannotated microproteins and identified smORFs essential for bacterial survival and involved in bacterial growth and virulence. Moreover, many smORFs are co-expressed and share operons with a myriad of biologically relevant genes and play a role in antibiotic response. Together, our data presents a resource of unknown genes that play a role in the success of Mtb as a widespread pathogen.

Open Access PDF

Concepts Keywords
Genome Bacterial Proteins
Mycobacterium Bacterial Proteins
Rich Genome, Bacterial
Spectrometry Micropeptides
Tuberculosis Micropeptides
Mycobacterium tuberculosis
Open Reading Frames
Proteogenomics
Proteome
Proteome

Semantics

Type Source Name
disease MESH Tuberculosis
pathway KEGG Tuberculosis
disease IDO process
disease IDO protein
disease IDO virulence
disease IDO role
drug DRUGBANK Spinosad
disease IDO pathogen
pathway KEGG Ribosome
pathway REACTOME Translation
drug DRUGBANK Ribostamycin
drug DRUGBANK Coenzyme M
disease IDO bacteria
drug DRUGBANK 5-amino-1 3 4-thiadiazole-2-thiol
drug DRUGBANK Gold
drug DRUGBANK Amino acids
drug DRUGBANK L-Valine
drug DRUGBANK L-Lysine
drug DRUGBANK L-Leucine
drug DRUGBANK L-Tyrosine
drug DRUGBANK Trypsin
pathway REACTOME Digestion
drug DRUGBANK Proline
drug DRUGBANK L-Arginine
drug DRUGBANK L-Cysteine
disease IDO site
drug DRUGBANK Ranitidine
disease MESH starvation
disease MESH infection
drug DRUGBANK Isoniazid
drug DRUGBANK Rifampicin
disease IDO antibiotic resistance
drug DRUGBANK Streptomycin
drug DRUGBANK Topiramate
drug DRUGBANK Huperzine B
disease IDO biological role
disease IDO quality
drug DRUGBANK Tromethamine
drug DRUGBANK Silicon dioxide
drug DRUGBANK Urea
drug DRUGBANK Formic Acid
drug DRUGBANK Flunarizine
drug DRUGBANK Ademetionine
drug DRUGBANK Aspartame
disease IDO cell
disease MESH drug interaction
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Bentiromide
pathway REACTOME Reproduction

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *